骨肽及复方骨肽注射液降压物质的研究  

Research on depressor substances of ossotide injection and compound ossotide injection

作　　者：邓利娟[1] 任雪[1] 范慧红[1] 

机构地区：[1]中国药品生物制品检定所,北京100050

出　　处：《中国生化药物杂志》2010年第4期231-234,共4页Chinese Journal of Biochemical Pharmaceutics

基　　金：国家科技支撑计划重点项目-药品注射剂检测技术体系研究(2008BA155B04)

摘　　要：目的建立骨肽注射液和复方骨肽注射液降压物质检查方法。方法采用猫血压法对骨肽及复方骨肽注射液降压物质进行了研究。结果骨肽注射液和复方骨肽注射液降压物质检查限值分别为原液0.3和0.2mL/kg。结论采用降压物质检查法控制骨肽注射液和复方骨肽注射液的质量是可行的。Purpose To establish the test for depressor substances of ossotide injection and compound ossotide injection.Methods The experiment was carried out with cats.Results The limits of ossotide injection and compound ossotide injection were 0.3 and 0.2 mL/kg respectively.Conclusion It is feasible to control quality of ossotide injection and compound ossotide injection by test for depressor substances.

关 键 词：骨肽注射液 复方骨肽注射液 降压物质 

分 类 号：R927.1[医药卫生—药学]